• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC. DIMENSION VISTA®; DIMENSION VISTA (BHCG) BETA HUMAN CHORIONIC GONADOTROPIN FLEX® REAGENT CARTRIDGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS INC. DIMENSION VISTA®; DIMENSION VISTA (BHCG) BETA HUMAN CHORIONIC GONADOTROPIN FLEX® REAGENT CARTRIDGE Back to Search Results
Model Number 10445107
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/04/2022
Event Type  malfunction  
Manufacturer Narrative
An outside of united states customer contacted the siemens healthcare diagnostics remote service center (rsc) regarding a falsely elevated beta human chorionic gonadotropin (bhcg) result obtained on a patient sample on a dimension vista 1500 system.Siemens is investigating the event.Mdrs 2517506-2022-00266, 2517506-2022-00267, 2517506-2022-00269, 2517506-2022-00270, 2517506-2022-00271, 2517506-2022-00272 and 2517506-2022-00273 were filed for the same event.
 
Event Description
A discordant falsely elevated beta human chorionic gonadotropin (bhcg) result was obtained on a patient sample on a dimension vista 1500 system.The result was reported to the physician(s).New samples were processed on later dates on alternate non-siemens systems and lower, negative results were obtained, considered correct, and reported.There are no known reports of patient intervention or adverse health consequences due to the falsely elevated bhcg result.
 
Manufacturer Narrative
Additional information (15-dec-2022): ): siemens healthcare diagnostics headquarters support center (hsc) concluded the investigation of the event.Hsc evaluated the information provided by the customer and concluded the event was not due to any issue with the beta human chorionic gonadotropin (bhcg) assay.There is no evidence of a potential product issue.Hsc reviewed the patient bhcg testing history and noted the consistently elevated bhcg results over multiple sample draws for the patient.A heterophile blocking study performed by the customer verified the presence of a non-specific binding interferent such as a heterophile antibody.The cause of the event is isolated to a patient specific issue.As stated in the limitations of procedure section of the dimension vista bhcg flex reagent cartridge instructions for use (ifu): "patient samples may contain heterophilic antibodies that could react in immunoassays to give falsely elevated or depressed results.This assay has been designed to minimize interference from heterophilic antibodies.Nevertheless, complete elimination of this interference from all patient specimens cannot be guaranteed.A test result that is inconsistent with the clinical picture and patient history should be interpreted with caution." the device is performing according to specifications.No further evaluation of this device is required.Section h6 has been updated to reflect siemens' investigation.Initial mdr 2517506-2022-00268 was filed on 07-oct-2022.Mdrs 2517506-2022-00266, 2517506-2022-00267, 2517506-2022-00269, 2517506-2022-00270, 2517506-2022-00271, 2517506-2022-00272 and 2517506-2022-00273 were filed for the same event.Mdr supplements 2517506-2022-00266 supplement 1, 2517506-2022-00267 supplement 1, 2517506-2022-00269 supplement 1, 2517506-2022-00270 supplement 1, 2517506-2022-00271 supplement 1, 2517506-2022-00272 supplement 1 and 2517506-2022-00273 supplement 1 were filed for the same event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DIMENSION VISTA®
Type of Device
DIMENSION VISTA (BHCG) BETA HUMAN CHORIONIC GONADOTROPIN FLEX® REAGENT CARTRIDGE
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
500 gbc drive
po box 6101
newark DE 19714 6101
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
500 gbc drive
po box 6101
newark DE 19714 6101
Manufacturer Contact
james morgera
500 gbc drive
po box 6101
newark, DE 19714-6101
MDR Report Key15561587
MDR Text Key304377594
Report Number2517506-2022-00268
Device Sequence Number1
Product Code DHA
UDI-Device Identifier00842768015540
UDI-Public00842768015540
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K063754
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/07/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/24/2023
Device Model Number10445107
Device Catalogue NumberK6430 SMN 10445107
Device Lot Number22024BB
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/15/2022
Was Device Evaluated by Manufacturer? No
Date Device Manufactured01/24/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age28 YR
Patient SexFemale
-
-